Skip to content
Clinical Trials – home
European Uro-Oncology Group Stichting
Sponsor

European Uro-Oncology Group Stichting

The Netherlands Zernikedreef 8, 2333 CL Leiden, The Netherlands

About the sponsor

Research activity is centered on upper tract urothelial carcinoma, also known as upper urinary tract transitional cell carcinoma, with attention to treatment pathways for patients undergoing surgical management. The clinical focus includes the role of cisplatin-based chemotherapy in relation to disease control.

  • Neoadjuvant chemotherapy
  • Adjuvant chemotherapy
  • Cisplatin-based treatment

Interest extends to how systemic therapy is integrated around surgery in this uro-oncology setting.

About Specializations

European Uro-Oncology Group Stichting runs clinical trials in conditions such as Transitional cell carcinoma, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Gemcitabine
  • Sponsor:European Uro-Oncology Group Stichting

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.